EGFR and breast cancer: Further elucidation of EGFR-driven mechanisms responsible for the activation of both ChoK-alpha or PC-PLC in BC cells may lead to novel multi-targeted anticancer therapies, whose effects could be preclinically and clinically monitored by MRS-based and optical metabolic imaging methods.